Results 281 to 290 of about 389,148 (301)

Resistance is futile: Targeting the inhibitory FcγRIIB (CD32B) to maximize immunotherapy

OncoImmunology, 2016
Ali Roghanian, Mark Cragg, Björn Frendeus   +2 more
exaly  

Immunohistochemical detection of CD14 and combined assessment with CD32B and CD68 for wound age estimation

Forensic Science International, 2016
Takuma Yamamoto, Kazuya Ikematsu
exaly  

Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell Malignancies

Molecular Cancer Therapeutics, 2020
Tuna Mutis
exaly  

Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid Leukemia

Clinical Cancer Research, 2016
U. Reusch, Kimberly H. Harrington, C. Gudgeon, Ivica Fucek, Kristina Ellwanger, M. Weichel, S. Knackmuss, E. Zhukovsky, J. Fox, L. Kunkel, J. Guenot, R. Walter   +11 more
semanticscholar   +1 more source

Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures

Nature, 1989
Christopher A. Smith, G. Williams, R. Kingston, E. Jenkinson, J. Owen   +4 more
semanticscholar   +1 more source

Anti-CD20/CD3 T cell–dependent bispecific antibody for the treatment of B cell malignancies

Science Translational Medicine, 2015
L. Sun, Diego A. Ellerman, M. Mathieu, Maria Hristopoulos, Xiaocheng Chen, Yijin Li, Xiao-Jie Yan, Robyn Clark, A. Reyes, E. Stefanich, Elaine Mai, J. Young, Clarissa Johnson, M. Huseni, Xinhua Wang, Yvonne M. Chen, Pei-Yin Wang, Hong Wang, N. Dybdal, Y. Chu, N. Chiorazzi, J. Scheer, T. Junttila, K. Totpal, M. Dennis, A. Ebens   +25 more
semanticscholar   +1 more source

Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo

Cancer Cell, 2015
Andrew Vaughan, Lekh N Dahal, Anne Ljungars   +2 more
exaly  

Development and characterisation of monoclonal antibodies specific for the murine inhibitory FcγRIIB (CD32B)

European Journal of Immunology, 2012
Ali Roghanian, Betty Lau, Mark Cragg
exaly  

Therapeutic control of B cell activation via recruitment of Fcγ receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffold

Arthritis and Rheumatism, 2010
Scott Koenig, Syd Johnson
exaly  

CD32B Expression Reflects Phenotypic and Functional Heterogeneity in Multiple Myeloma (MM)

Blood, 2008
Qianxing Mo, Raymond Comenzo
exaly